Plus Therapeutics to Participate in Upcoming January Conferences

AUSTIN, Texas, Jan. 05, 2021 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage company focused on making a positive impact on patients’ lives, today announced that Marc Hedrick, M.D., President and Chief Executive Officer of Plus Therapeutics, will present at three upcoming virtual conferences.
Investors interested in arranging a meeting with the Company’s management during the ICR Conference 2021 should contact the conference coordinator or brandon.weiner@westwicke.com. Webcasts of the H.C. Wainwright and ICR conferences presentations will be available under the ‘Events’ tab of the Investor Relations section of the Plus Therapeutics website at www.plustherapeutics.com.
About Plus Therapeutics, Inc.